Ischaemic Stroke – Current aspects concerning prevention: We need to act

Detalhes bibliográficos
Autor(a) principal: Silva, Francisco
Data de Publicação: 2004
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://revista.spmi.pt/index.php/rpmi/article/view/1748
Resumo: Stroke is the main cause of morbidity and mortality in Portugal. Modern Medicine is contributing to increase the mean age of the population and consequently, the numbers of patients with stroke. Thrombolysis, recently approved in Europe, benefits only a minority of patients. Thus, we consider that the only form of reducing the incidence of this disease is by controlling risk factors. In this article we emphasize the importance of primary prevention and review risk factors most strongly related to stroke, with special attention to the controllable ones, namely hypertension and dyslipidemia, among others. Recent trials that clarify the role of statins and ACE-inhibitors in primary and secondary stroke prevention are reviewed. The importance of a healthy doctor-patient relationship, as well as the need for global information strategies, are underlined as the fundamental means to achieve patient compliance with the preventive measures proposed.
id RCAP_b8422d1efc175897d1a0b114a6bb243e
oai_identifier_str oai:oai.revista.spmi.pt:article/1748
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Ischaemic Stroke – Current aspects concerning prevention: We need to actAcidente vascular cerebral isquémico – Prevenção: Aspectos actuais – É preciso agirAcidente Vascular Cerebralprevençãofactores de riscohipertensão arteriallipidosantiagregação plaquetáriaestatinasInibidores da ECAstrokerisk factorshypertensionlipidsstatinsACE-inhibitorsanti-platelet aggregationStroke is the main cause of morbidity and mortality in Portugal. Modern Medicine is contributing to increase the mean age of the population and consequently, the numbers of patients with stroke. Thrombolysis, recently approved in Europe, benefits only a minority of patients. Thus, we consider that the only form of reducing the incidence of this disease is by controlling risk factors. In this article we emphasize the importance of primary prevention and review risk factors most strongly related to stroke, with special attention to the controllable ones, namely hypertension and dyslipidemia, among others. Recent trials that clarify the role of statins and ACE-inhibitors in primary and secondary stroke prevention are reviewed. The importance of a healthy doctor-patient relationship, as well as the need for global information strategies, are underlined as the fundamental means to achieve patient compliance with the preventive measures proposed.O Acidente Vascular Cerebral (AVC) é a patologia com maior mortalidade e morbilidade em Portugal. A Medicina moderna tem contribuído para um aumento da população idosa e, consequentemente, aumento do número de doentes com AVC. A trombólise, recentemente aprovada na Europa, apenas beneficia um número muito restrito de doentes. Assim, consideramos que a única forma de tentar diminuir a incidência desta doença consiste no controlo dos factores de risco. Neste artigo salienta-se a importância da terapêutica preventiva, abordam-se os factores de risco mais frequentemente relacionados com o AVC, com especial ênfase para aqueles que podem ser controlados, nomeadamente a hipertensão arterial e a dislipidemia, entre outros. Abordam-se os novos estudos que clarificam o papel das estatinas e dos inibidores do enzima conversor da angiotensina na prevenção primária e secundária do AVC. Chama-se a atenção para a empatia necessária entre médico-doente para uma melhor aderência às medidas preventivas propostas. Salienta-se a importância de campanhas globais de informação como medida fundamental na diminuição da incidência do AVC.Sociedade Portuguesa de Medicina Interna2004-06-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://revista.spmi.pt/index.php/rpmi/article/view/1748Internal Medicine; Vol. 11 No. 2 (2004): Abril/ Junho; 99-108Medicina Interna; Vol. 11 N.º 2 (2004): Abril/ Junho; 99-1082183-99800872-671Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revista.spmi.pt/index.php/rpmi/article/view/1748https://revista.spmi.pt/index.php/rpmi/article/view/1748/1210Silva, Franciscoinfo:eu-repo/semantics/openAccess2023-04-01T06:11:34Zoai:oai.revista.spmi.pt:article/1748Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:48:17.064844Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Ischaemic Stroke – Current aspects concerning prevention: We need to act
Acidente vascular cerebral isquémico – Prevenção: Aspectos actuais – É preciso agir
title Ischaemic Stroke – Current aspects concerning prevention: We need to act
spellingShingle Ischaemic Stroke – Current aspects concerning prevention: We need to act
Silva, Francisco
Acidente Vascular Cerebral
prevenção
factores de risco
hipertensão arterial
lipidos
antiagregação plaquetária
estatinas
Inibidores da ECA
stroke
risk factors
hypertension
lipids
statins
ACE-inhibitors
anti-platelet aggregation
title_short Ischaemic Stroke – Current aspects concerning prevention: We need to act
title_full Ischaemic Stroke – Current aspects concerning prevention: We need to act
title_fullStr Ischaemic Stroke – Current aspects concerning prevention: We need to act
title_full_unstemmed Ischaemic Stroke – Current aspects concerning prevention: We need to act
title_sort Ischaemic Stroke – Current aspects concerning prevention: We need to act
author Silva, Francisco
author_facet Silva, Francisco
author_role author
dc.contributor.author.fl_str_mv Silva, Francisco
dc.subject.por.fl_str_mv Acidente Vascular Cerebral
prevenção
factores de risco
hipertensão arterial
lipidos
antiagregação plaquetária
estatinas
Inibidores da ECA
stroke
risk factors
hypertension
lipids
statins
ACE-inhibitors
anti-platelet aggregation
topic Acidente Vascular Cerebral
prevenção
factores de risco
hipertensão arterial
lipidos
antiagregação plaquetária
estatinas
Inibidores da ECA
stroke
risk factors
hypertension
lipids
statins
ACE-inhibitors
anti-platelet aggregation
description Stroke is the main cause of morbidity and mortality in Portugal. Modern Medicine is contributing to increase the mean age of the population and consequently, the numbers of patients with stroke. Thrombolysis, recently approved in Europe, benefits only a minority of patients. Thus, we consider that the only form of reducing the incidence of this disease is by controlling risk factors. In this article we emphasize the importance of primary prevention and review risk factors most strongly related to stroke, with special attention to the controllable ones, namely hypertension and dyslipidemia, among others. Recent trials that clarify the role of statins and ACE-inhibitors in primary and secondary stroke prevention are reviewed. The importance of a healthy doctor-patient relationship, as well as the need for global information strategies, are underlined as the fundamental means to achieve patient compliance with the preventive measures proposed.
publishDate 2004
dc.date.none.fl_str_mv 2004-06-30
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revista.spmi.pt/index.php/rpmi/article/view/1748
url https://revista.spmi.pt/index.php/rpmi/article/view/1748
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revista.spmi.pt/index.php/rpmi/article/view/1748
https://revista.spmi.pt/index.php/rpmi/article/view/1748/1210
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Medicina Interna
publisher.none.fl_str_mv Sociedade Portuguesa de Medicina Interna
dc.source.none.fl_str_mv Internal Medicine; Vol. 11 No. 2 (2004): Abril/ Junho; 99-108
Medicina Interna; Vol. 11 N.º 2 (2004): Abril/ Junho; 99-108
2183-9980
0872-671X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131565874216960